This brand name is authorized in United Kingdom
The drug NEO-NACLEX contains one active pharmaceutical ingredient (API):
|
1
Bendroflumethiazide
UNII 5Q52X6ICJI - BENDROFLUMETHIAZIDE
|
|
Bendroflumethiazide inhibits the renal tubular absorption of salt and water by its action at the beginning of the distal convoluted tubule. Sodium and chloride ions are excreted in equivalent proportions. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C03AA01 | Bendroflumethiazide | C Cardiovascular system → C03 Diuretics → C03A Low-ceiling diuretics, thiazides → C03AA Thiazides, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 181491 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
